MLchartDataset catalogue

Leukeran

Term · Oncology and biomedicine · MLC-T-ONC-004797

A drug used to treat chronic lymphocytic leukemia, Hodgkin lymphoma, and certain types of non-Hodgkin lymphoma. It is also being studied in the treatment of other types of cancer. Leukeran damages the cell’s DNA and may kill cancer cells. It is a type of alkylating agent. Also called chlorambucil.

Table 1. Record
IdentifierMLC-T-ONC-004797
FieldOncology and biomedicine
Synonymschlorambucil
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-004797",
  "term": "Leukeran",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat chronic lymphocytic leukemia, Hodgkin lymphoma, and certain types of non-Hodgkin lymphoma. It is also being studied in the treatment of other types of cancer. Leukeran damages the cell’s DNA and may kill cancer cells. It is a type of alkylating agent. Also called chlorambucil.",
  "synonyms": [
    "chlorambucil"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/leukeran/"
}

Record 10,043 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.